select a format

Single User License
USD 250 INR 16198
Site License
USD 500 INR 32395
Corporate User License
USD 750 INR 48593

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Bessemer Venture Partners-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Bessemer Venture Partners-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH143676D
  • |
  • Pages: 64
  • |
  • November 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Bessemer Venture Partners (BVP) is a venture capital firm that provides investment management solutions. The firm offers healthcare and related technology and services.It also provides investment in banking; and software, platform and infrastructures as a service. BVP ventures in the areas of cleantech, cloud computing, cyber security, financial services, healthcare, infrastructure, mobile and online retail, among others. It caters B2D, cloud and SaaS, mobile, data center, infrastructure, networking, security, Space technology and storage. The company has its presence in the US, India, and Israel. BVP is headquartered in Larchmont, New York, the US.

Bessemer Venture Partners-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Bessemer Venture Partners, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Bessemer Venture Partners, Medical Devices Deals, 2010 to YTD 2016 10

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deal Details 16

Venture Financing 16

Allena Pharma Raises USD25 Million in Series B Venture Financing 16

Flex Pharma Raises USD40 Million in Venture Financing 18

NephroPlus Raises USD10 Million in Series B Financing 20

Proteon Therapeutics Raises USD45 Million in Series D Financing 21

Alcresta Raises US$10 Million In Series B Financing 24

Health Essentials Raises US$51 Million In Venture Financing 26

Alcresta Raises US$10 Million In Series A Financing 28

OvaScience Raises US$37 Million In Series B Financing 30

Atopix Raises USD5.7 Million in Series A Financing Round 32

NephroPlus Raises USD4 Million in Venture Financing 34

Cerulean Pharma Secures US$15 Million In Series D Financing 35

NephroPlus Raises US$37 Million In Venture Financing 37

Allena Pharma Secures US$15 Million In Series A Financing 38

Proteon Therapeutics Secures US$15.2 Million In Venture Financing 39

OvaScience Secures US$6 Million In Series A Financing 41

Verastem Secures US$32 Million In Series B Financing 42

Verastem Secures US$16 Million In Series A Round Of Financing 44

Cerulean Pharma Secures US$24 Million In Series C Financing 46

Oxagen Raises US$33 Million In Series C Financing 48

Alnara Pharma Raises US$35 Million In Series B Financing 51

Acquisition 53

Biogen Idec Completes Acquisition Of Remaining Stake In Stromedix, Provider Of Therapies For Fibrosis 53

Insmed Acquires Transave 56

Eli Lilly Acquires Alnara Pharma 59

Bessemer Venture Partners-Key Competitors 61

Key Employees 62

Locations And Subsidiaries 63

Head Office 63

Other Locations & Subsidiaries 63

Appendix 64

Methodology 64

About GlobalData 64

Contact Us 64

Disclaimer 64

List of Figures

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

Bessemer Venture Partners, Medical Devices Deals, 2010 to YTD 2016 10

List of Tables

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Key Facts 1

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5

Bessemer Venture Partners, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7

Bessemer Venture Partners, Deals By Therapy Area, 2010 to YTD 2016 8

Bessemer Venture Partners, Medical Devices Deals, 2010 to YTD 2016 10

Bessemer Venture Partners, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11

Allena Pharma Raises USD25 Million in Series B Venture Financing 16

Flex Pharma Raises USD40 Million in Venture Financing 18

NephroPlus Raises USD10 Million in Series B Financing 20

Proteon Therapeutics Raises USD45 Million in Series D Financing 21

Alcresta Raises US$10 Million In Series B Financing 24

Health Essentials Raises US$51 Million In Venture Financing 26

Alcresta Raises US$10 Million In Series A Financing 28

OvaScience Raises US$37 Million In Series B Financing 30

Atopix Raises USD5.7 Million in Series A Financing Round 32

NephroPlus Raises USD4 Million in Venture Financing 34

Cerulean Pharma Secures US$15 Million In Series D Financing 35

NephroPlus Raises US$37 Million In Venture Financing 37

Allena Pharma Secures US$15 Million In Series A Financing 38

Proteon Therapeutics Secures US$15.2 Million In Venture Financing 39

OvaScience Secures US$6 Million In Series A Financing 41

Verastem Secures US$32 Million In Series B Financing 42

Verastem Secures US$16 Million In Series A Round Of Financing 44

Cerulean Pharma Secures US$24 Million In Series C Financing 46

Oxagen Raises US$33 Million In Series C Financing 48

Alnara Pharma Raises US$35 Million In Series B Financing 51

Biogen Idec Completes Acquisition Of Remaining Stake In Stromedix, Provider Of Therapies For Fibrosis 53

Insmed Acquires Transave 56

Eli Lilly Acquires Alnara Pharma 59

Bessemer Venture Partners, Key Competitors 61

Bessemer Venture Partners, Key Employees 62

Bessemer Venture Partners, Other Locations 63

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Bessemer Venture Partners, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com